We are monitoring the impact of COVID-19 on DNA Sequencing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 10636
Share on
Share on

Global DNA Sequencing Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product & Services, Technology, Workflow, Application, End User, and Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 10636
Pages: 190

Global DNA Sequencing Market Size (2021 to 2026)

The global DNA sequencing market size is forecasted to hike at a CAGR of 14.2% from 2021 to 2026. This market is estimated to worth USD 11.14 billion by 2026 and USD 5.73 billion in 2021.

The DNA sequence is used to identify the structure of a DNA molecule in laboratories. Researchers will require this information to identify the genetic data of a DNA molecule and to understand its function in the body.


The global DNA sequencing market is majorly driven by its high accuracy rate/speed rate. Getting accurate results from low sample input is offered by DNA sequencing over the microarray and other genomic analysis methods. Additionally, the DNA sequencing market's cost-effective nature is also favoring the growth rate of the market. DNA sequencing can be used for various applications such as drug discovery, oncology studies, personalized medicine, forensics, biomarkers, etc.

Furthermore, factors such as a surge in sequencing applications, growing R & D investments, the increase in the numerous genome mapping programs, and technological advancements are also fuelling the growth of the global DNA sequencing market.


Some of the significant restraints that are holding back the growth of the DNA sequencing market are prohibitive cost, repetition of content, and also the expertise of professionals.




Market Size Available

2020 to 2026

Base Year


Forecast Period

2021 to 2026

Segments Covered

Based on the Product & Services, Technology, Workflow, Application, End User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa


This research report on the global DNA sequencing market has been segmented and sub-segmented based on the product & services, technology, workflow, application, end-user, and region.

DNA Sequencing Market – By Product & Services:

  • Consumables
  • Instruments
  • Services

Based on the product & services, the revenue share of 39.4% value is registered by the Consumables segment in 2020. The consumables segment has a wide range of kits and reagents for all library construction steps, such as enrichment, adapter ligation, quality control, and DNA fragmentation.

The services segment is favored by high accuracy in performances, high experiment team assists, and advanced technology. During the forecast period, the highest compound annual growth rate is expected to register by the services segment due to the rapid turnaround time, support from the technical side, and outstanding customer services.

DNA Sequencing Market – By Technology:

  • Sanger Sequencing
  • Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
  • Third Generation DNA Sequencing  
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

Based on thTheare is accounting for by the Next-Generation Sequencing segment with dominancy by revenue share of 60.2%. Factors s based on technology, such as the radical advancement of technology and declination in cost of sequences, are significantly supported in this segment.

Nanopore and single-molecule real-time sequencing are various methods of third-generation sequencing and other lucrative segments in this market. Rapid usage of third-generation DNA sequencing with a comparison of second-generation techniques by including easy sample preparations helps these segments make a stand.

DNA Sequencing Market – By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

Based on the workflow, the sequencing segment was accounted for a market share of 49.8% in 2019. The growing data volume will accelerate the understanding of humans' health to treat diseases, which is a favorable factor for this market to grow.

During the forecast period, the largest share is contributing by Data Analysis with high growth-share due to the generation of notable profits to run already existing genomics software, reduce the prices, and create new data centers. Moreover, the advancement of technology will further help to analyze massive processes. These factors are attributing the largest share in the Data Analysis segment.

DNA Sequencing Market – By Application:

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agrigenomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others

In 2019, most of the share was contributed by the oncology segment, i.e., 29.5%. Due to factors such as technological advancements, development of cancer diagnostics and therapeutics, high-throughput can afford in the identity of characters in clinically actionable generic variants among numerous genes at exceptional speed.

The quickest growing segment is consumer genomics and expected to register the highest growth rate during the forecast period. Genealogy, personal health awareness, ancestry, and paternity testing are parts of rapid proliferation. Biotechnology companies like Helix Opto LLC and AncestryDNA are some of the factors attributing to the consumer genomics segment in the forecast period.

DNA Sequencing Market – By End-use:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

Based on the end-user, the academic research segment was accounted for the lion's share of the market in 2019 and predicted to continue its domination during the forecast period. Factors such as wide acceptance of technology in an advanced stage and the rapid rise of investments in funds are majorly accelerating this segment.

DNA Sequencing Market – By Region:

  • North America
    • The United States
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of EU
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America
  • The Middle East and Africa

Among all the regions, the North American DNA sequencing market is expected to dominate the global market during the forecast period. The rise in the prevalence of cancer, the growing geriatric population, and the development of innovation ecology favor the North American market. Moreover, major market key players in this region and large buying power are further adding fuel to the market to grow further.

The European DNA sequencing market was the second leading region globally in 2019 and is predicted to register a robust CAGR between 2020 to 2025. The rise in the aging population and the increase in the patient's count suffering from cancer, sedentary lifestyle, and efficient reimbursement scenarios are expected to favor the European market growth.

Due to many patients, the Asia-pacific DNA sequencing market is predicted to hike at a significant rate during the forecast period. Moreover, improving healthcare infrastructure and increasing healthcare expenditure in this region is a big plus to the global market.

As expected, the lowest share was contributed by the Middle East and Africa region in 2019. Some of the hampers are a shortage of advanced technologies and having poor medical facilities.


Agilent Technologies, Inc., Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc. are some of the companies dominating the global DNA sequencing market.


  • In August 2020, NovaSeq 6000 v1.5 Reagent Kit was launched by Illumina Inc. that kit was made for the WGS technique with high cost-effectiveness. This is accessed to all laboratories and also helps to reduce cost.
  • In August 2020, to guide cancer treatment, an FDA provision was made for the first liquid biopsy companion diagnostic by leveraging NGS technology.
  • In April 2020, EUA was received from Helix OpCo LLC for Helix COVID-19 NGS Test to detect SARS-CoV-2 infection.
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
    1. Products and Services
      1. Consumables
      2. Instruments
      3. Services
      4. Y-o-Y Growth Analysis, By Products and Services
      5. Market Attractiveness Analysis, By Products and Services
      6. Market Share Analysis, By Products and Services
    2. By Technology
      1. Sanger Sequencing
      2. Next-Generation Sequencing
      3. Whole Genome Sequencing (WGS)
      4. Whole Exome Sequencing (WES)
      5. Targeted Sequencing & Resequencing
      6. Third Generation DNA Sequencing  
      7. Single-Molecule Real-Time Sequencing (SMRT)
      8. Nanopore Sequencing
      9. Y-o-Y Growth Analysis, By Technology
      10. Market Attractiveness Analysis, By Technology
      11. Market Share Analysis, By Technology
    3. By Workflow
      1. Pre-sequencing
      2. Sequencing
      3. Data Analysis
      4. Y-o-Y Growth Analysis, By Workflow
      5. Market Attractiveness Analysis, By Workflow
      6. Market Share Analysis, By Workflow
    4. By Application
      1. Oncology
      2. Reproductive Health
      3. Clinical Investigation
      4. Agri genomics & Forensics
      5. HLA Typing/Immune System Monitoring
      6. Metagenomics, Epidemiology & Drug Development
      7. Consumer Genomics
      8. Others
      9. Y-o-Y Growth Analysis, By Application
      10. Market Attractiveness Analysis, By Application
      11. Market Share Analysis, By Application
    5. By End-User
      1. Academic Research
      2. Clinical Research
      3. Hospitals & Clinics
      4. Pharmaceutical & Biotechnology Companies
      5. Other Users
      6. Y-o-Y Growth Analysis, By End User
      7. Market Attractiveness Analysis, By End User
      8. Market Share Analysis, By End User
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. North America
      1. Introduction
      2. United States
      3. Canada
    3. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
      7. Rest of Europe
    4. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia and NZ
      7. Rest of APAC
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
      5. Rest of Latin America
    6. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. Africa
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
    1. Abbott Laboratories
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Agilent Technologies, Inc.
    3. Danaher Corporation (Beckman Coulter, Inc.)
    4. F. Hoffmann-La Roche Ltd
    5. Illumina, Inc.
    6. LI-COR Biosciences, Inc.
    7.  Pacific Biosciences of California, Inc.
    8.  SIEMENS AG
    9. PerkinElmer Inc.,
    10. Thermo Fisher Scientific, Inc.
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations, and Joint Ventures
    4. New Product Launches
  13. List of Tables
  14. List of Figures
  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and identify the regions that are still untapped.
  • The segment-level analysis in terms of products and services, workflow, application, and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, including broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine an Industry's overall profitability, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players and their proDNA Sequencing Marketduct portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field, new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary abridges the entire report so that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview and investment opportunities to provide both individuals and organizations a strong financial foothold in the market.

DNA Sequencing Market

Please wait. . . . Your request is being processed

Related Reports


$ 1234 4255

Click for Request Sample